PI: Willem Mulder, Ph.D.

 Professor of Radiology, ISMMS

 Professor of Cardiovascular Nanomedicine, AMC

 Director, Nanomedicine Program

I obtained an M.Sc. in Chemistry from the Utrecht University (2001) and a Ph.D. in Biomedical Engineering from the Eindhoven University of Technology (2006). 

‚Äč

In 2006, directly after my recruitment to Icahn School of Medicine at Mount Sinai (ISMMS) in New York, I founded the Nanomedicine lab, one of four programs within Sinai’s Translational and Molecular Imaging Institute. Since January 2012, I distribute my research activities between ISMMS and the AMC in Amsterdam. This has been a successful setup, allowing fluid exchange of resources, knowhow and personnel between both places.

 

My research focuses on precision imaging and targeted therapy in cardiovascular disease, cancer and transplantation. I have established library technology, encompassing nanomaterials derived from natural lipoproteins (nanobiologics), that allows meticulously designing targeted immunotherapies. When appropriately designed, such nanobiologics can be applied to empower the immune system’s ability to fight disease, by promoting or inhibiting an immune response, by polarizing macrophage function, or by targeting myeloid cell dynamics.